• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从异质人群中检测出与生存相关的生物标志物。

Detecting survival-associated biomarkers from heterogeneous populations.

机构信息

Department of Mathematics, University of Maryland, College Park, MD, 20742, USA.

Department of Epidemiology and Biostatistics, University of Maryland, College Park, MD, 20740, USA.

出版信息

Sci Rep. 2021 Feb 5;11(1):3203. doi: 10.1038/s41598-021-82332-y.

DOI:10.1038/s41598-021-82332-y
PMID:33547332
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7865037/
Abstract

Detection of prognostic factors associated with patients' survival outcome helps gain insights into a disease and guide treatment decisions. The rapid advancement of high-throughput technologies has yielded plentiful genomic biomarkers as candidate prognostic factors, but most are of limited use in clinical application. As the price of the technology drops over time, many genomic studies are conducted to explore a common scientific question in different cohorts to identify more reproducible and credible biomarkers. However, new challenges arise from heterogeneity in study populations and designs when jointly analyzing the multiple studies. For example, patients from different cohorts show different demographic characteristics and risk profiles. Existing high-dimensional variable selection methods for survival analysis, however, are restricted to single study analysis. We propose a novel Cox model based two-stage variable selection method called "Cox-TOTEM" to detect survival-associated biomarkers common in multiple genomic studies. Simulations showed our method greatly improved the sensitivity of variable selection as compared to the separate applications of existing methods to each study, especially when the signals are weak or when the studies are heterogeneous. An application of our method to TCGA transcriptomic data identified essential survival associated genes related to the common disease mechanism of five Pan-Gynecologic cancers.

摘要

检测与患者生存结果相关的预后因素有助于深入了解疾病并指导治疗决策。高通量技术的快速发展产生了大量的基因组生物标志物作为候选预后因素,但大多数在临床应用中作用有限。随着技术价格的降低,许多基因组研究在不同的队列中进行,以探索一个共同的科学问题,从而确定更具可重复性和可信度的生物标志物。然而,当联合分析多个研究时,来自研究人群和设计的异质性带来了新的挑战。例如,来自不同队列的患者表现出不同的人口统计学特征和风险状况。然而,现有的用于生存分析的高维变量选择方法仅限于单研究分析。我们提出了一种新的基于 Cox 模型的两阶段变量选择方法,称为“Cox-TOTEM”,用于检测多个基因组研究中共同存在的与生存相关的生物标志物。模拟结果表明,与将现有方法分别应用于每个研究相比,我们的方法大大提高了变量选择的灵敏度,尤其是在信号较弱或研究存在异质性时。我们的方法在 TCGA 转录组数据中的应用确定了与五种妇科癌症共同疾病机制相关的重要生存相关基因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306d/7865037/e7074198ef0d/41598_2021_82332_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306d/7865037/cf586b51ce1e/41598_2021_82332_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306d/7865037/2d5cf663529f/41598_2021_82332_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306d/7865037/e7074198ef0d/41598_2021_82332_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306d/7865037/cf586b51ce1e/41598_2021_82332_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306d/7865037/2d5cf663529f/41598_2021_82332_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306d/7865037/e7074198ef0d/41598_2021_82332_Fig3_HTML.jpg

相似文献

1
Detecting survival-associated biomarkers from heterogeneous populations.从异质人群中检测出与生存相关的生物标志物。
Sci Rep. 2021 Feb 5;11(1):3203. doi: 10.1038/s41598-021-82332-y.
2
Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer.基于乳腺癌元维度组学数据间的相互作用预测删失生存数据。
J Biomed Inform. 2015 Aug;56:220-8. doi: 10.1016/j.jbi.2015.05.019. Epub 2015 Jun 3.
3
Assessing the clinical utility of genomic expression data across human cancers.评估基因组表达数据在人类癌症中的临床应用价值。
Oncotarget. 2016 Jul 19;7(29):45926-45936. doi: 10.18632/oncotarget.10002.
4
Network-based survival analysis reveals subnetwork signatures for predicting outcomes of ovarian cancer treatment.基于网络的生存分析揭示了用于预测卵巢癌治疗结果的子网签名。
PLoS Comput Biol. 2013;9(3):e1002975. doi: 10.1371/journal.pcbi.1002975. Epub 2013 Mar 21.
5
Identification of a Tumor Microenvironment-relevant Gene set-based Prognostic Signature and Related Therapy Targets in Gastric Cancer.基于肿瘤微环境相关基因集的胃癌预后特征及相关治疗靶点的鉴定。
Theranostics. 2020 Jul 9;10(19):8633-8647. doi: 10.7150/thno.47938. eCollection 2020.
6
Multi-omics facilitated variable selection in Cox-regression model for cancer prognosis prediction.多组学技术助力Cox回归模型中的变量选择以进行癌症预后预测。
Methods. 2017 Jul 15;124:100-107. doi: 10.1016/j.ymeth.2017.06.010. Epub 2017 Jun 13.
7
Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.早期非鳞状非小细胞肺癌个体化免疫预后标志物的建立与验证。
JAMA Oncol. 2017 Nov 1;3(11):1529-1537. doi: 10.1001/jamaoncol.2017.1609.
8
Identification of prognostic biomarkers for major subtypes of non-small-cell lung cancer using genomic and clinical data.利用基因组和临床数据鉴定非小细胞肺癌主要亚型的预后生物标志物。
J Cancer Res Clin Oncol. 2020 Nov;146(11):2743-2752. doi: 10.1007/s00432-020-03318-3. Epub 2020 Jul 14.
9
Clinically applicable 53-Gene prognostic assay predicts chemotherapy benefit in gastric cancer: A multicenter study.临床适用的 53 基因预后检测可预测胃癌的化疗获益:一项多中心研究。
EBioMedicine. 2020 Nov;61:103023. doi: 10.1016/j.ebiom.2020.103023. Epub 2020 Oct 14.
10
Identification of potential biomarkers related to glioma survival by gene expression profile analysis.通过基因表达谱分析鉴定与胶质瘤生存相关的潜在生物标志物。
BMC Med Genomics. 2019 Mar 20;11(Suppl 7):34. doi: 10.1186/s12920-019-0479-6.

引用本文的文献

1
CoxKAN: Kolmogorov-Arnold networks for interpretable, high-performance survival analysis.CoxKAN:用于可解释的高性能生存分析的柯尔莫哥洛夫 - 阿诺德网络
Bioinformatics. 2025 Aug 2;41(8). doi: 10.1093/bioinformatics/btaf413.
2
FRL: An Integrative Feature Selection Algorithm Based on the Fisher Score, Recursive Feature Elimination, and Logistic Regression to Identify Potential Genomic Biomarkers.FRL:一种基于 Fisher 得分、递归特征消除和逻辑回归的综合特征选择算法,用于识别潜在的基因组生物标志物。
Biomed Res Int. 2021 Jun 12;2021:4312850. doi: 10.1155/2021/4312850. eCollection 2021.

本文引用的文献

1
A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily.泛癌症分析揭示 TGF-β 超家族信号转导介质中的高频遗传改变。
Cell Syst. 2018 Oct 24;7(4):422-437.e7. doi: 10.1016/j.cels.2018.08.010. Epub 2018 Sep 26.
2
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.起源细胞模式主导了 33 种癌症类型的 10000 个肿瘤的分子分类。
Cell. 2018 Apr 5;173(2):291-304.e6. doi: 10.1016/j.cell.2018.03.022.
3
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers.
妇科和乳腺癌的全面泛癌分子研究。
Cancer Cell. 2018 Apr 9;33(4):690-705.e9. doi: 10.1016/j.ccell.2018.03.014. Epub 2018 Apr 2.
4
Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types.剪接因子基因的体细胞突变景观及其在 33 种癌症类型中的功能后果。
Cell Rep. 2018 Apr 3;23(1):282-296.e4. doi: 10.1016/j.celrep.2018.01.088.
5
Quantitative mapping of RNA-mediated nuclear estrogen receptor β interactome in human breast cancer cells.RNA 介导的核雌激素受体 β 相互作用组在人乳腺癌细胞中的定量作图。
Sci Data. 2018 Mar 6;5:180031. doi: 10.1038/sdata.2018.31.
6
Meta-analytic framework for sparse -means to identify disease subtypes in multiple transcriptomic studies.用于在多个转录组学研究中识别疾病亚型的稀疏均值荟萃分析框架。
J Am Stat Assoc. 2016;111(513):27-42. doi: 10.1080/01621459.2015.1086354. Epub 2016 May 5.
7
MetaKTSP: a meta-analytic top scoring pair method for robust cross-study validation of omics prediction analysis.MetaKTSP:一种用于组学预测分析的稳健跨研究验证的元分析最高得分对方法。
Bioinformatics. 2016 Jul 1;32(13):1966-73. doi: 10.1093/bioinformatics/btw115. Epub 2016 Mar 2.
8
Regularization Paths for Cox's Proportional Hazards Model via Coordinate Descent.通过坐标下降法求解Cox比例风险模型的正则化路径
J Stat Softw. 2011 Mar;39(5):1-13. doi: 10.18637/jss.v039.i05.
9
Single Gene Prognostic Biomarkers in Ovarian Cancer: A Meta-Analysis.卵巢癌中的单基因预后生物标志物:一项荟萃分析。
PLoS One. 2016 Feb 17;11(2):e0149183. doi: 10.1371/journal.pone.0149183. eCollection 2016.
10
Pan-cancer analysis of the extent and consequences of intratumor heterogeneity.肿瘤内异质性程度及后果的泛癌分析
Nat Med. 2016 Jan;22(1):105-13. doi: 10.1038/nm.3984. Epub 2015 Nov 30.